Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells

Signe R Michaelsen, Camilla L Christensen, Maxwell Sehested, Frederik Cramer, Thomas T Poulsen, Adam V Patterson, Hans S Poulsen

13 Citationer (Scopus)

Abstract

Transcriptional targeted suicide gene (SG) therapy driven by the insulinoma-associated 1 (INSM1) promoter makes it possible to target suicide toxin production and cytotoxicity exclusively to small cell lung cancer (SCLC) cells and tumors. It remains to be determined whether acquired chemoresistance, as observed in the majority of SCLC patients, desensitizes SCLC cells to INSM1 promoter-driven SG therapy.
OriginalsprogEngelsk
TidsskriftThe journal of gene medicine
Vol/bind14
Udgave nummer7
Sider (fra-til)445-58
Antal sider14
ISSN1943-961X
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells'. Sammen danner de et unikt fingeraftryk.

Citationsformater